Evidence mapPaperPMID 42056104Full record

ArticleNature communications2026

Mapping functional non-coding variation in individual human genomes through haplotyping, multiomics, and deep learning.

Mikhail D Magnitov, Robin H van der Weide, Aster F Witvliet, Miguel Hernández-Quiles, Moreno Martinović, Hans Teunissen, Luca Braccioli, Michiel Vermeulen, Elzo de Wit

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mikhail D MagnitovDivision of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Robin H van der Weide *Division of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-6466-7280
Aster F Witvliet *Division of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Miguel Hernández-QuilesDivision of Molecular Genetics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Moreno MartinovićDivision of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Hans TeunissenDivision of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Luca BraccioliDivision of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Michiel VermeulenDivision of Molecular Genetics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0836-6894
Elzo de WitDivision of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands. e.d.wit@nki.nl.ORCID http://orcid.org/0000-0003-2883-1415

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 637587 HAP-PHENEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 865459 FuncDis3DKWF Kankerbestrijding (Dutch Cancer Society) NAMinisterie van Volksgezondheid, Welzijn en Sport (Dutch Ministry of Health, Welfare and Sport) NANederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) 016.161.316, Vidi
6 · The paper itself

Abstract

Most genetic variants in the human genome reside in non-coding regions, where they can perturb regulatory element activity to influence gene expression, thereby contributing to various phenotypes and diseases. However, identifying functionally relevant non-coding genetic variation remains challenging. Here we integrate personal genomics, allele-specific gene regulation, and deep learning predictions to map the impact of non-coding variation in its native allelic and regulatory context. Leveraging whole-chromosome haplotypes and allele-specific analyses, we establish regulatory links within individual human genomes, enabling us to evaluate functional consequences of both common and rare variants. We identify and validate hundreds of cell-type-specific transcription factor binding events disrupted by genetic variants, revealing known and novel mechanisms that underlie allele-specific chromatin accessibility and gene expression. Using this framework, we discovered a rare variant that disrupted an OCT2 binding site within a distal enhancer, thereby modulating the expression of PIK3R5 gene. Our study establishes a generalisable strategy for interpreting non-coding regulatory variation, enabling systematic dissection of variant effects across diverse biological systems and offering a framework to investigate disease mechanisms.

Indexed as

Deep LearningGenetic VariationGenome, HumanHaplotypesAllelesBinding SitesChromatinEnhancer Elements, GeneticGene Expression RegulationGenomicsHumansMultiomicsPolymorphism, Single NucleotideTranscription FactorsChromatinTranscription Factors

Identifiers

PMID42056104
PMCPMC13333882

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.